Critic at Large

» disease/medicine and culture

Most Recent

image: Going Beyond the Lab

Going Beyond the Lab

By | July 1, 2014

Scientists who study the biological roots of sexual orientation should continue working with educators, policy-makers, and the public to put their data to good use.

10 Comments

image: To Study Unfettered

To Study Unfettered

By | July 1, 2014

Researching the causes of sexual orientation should be guided by scientific, not social, concerns.

5 Comments

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.

2 Comments

image: On Race and Medicine

On Race and Medicine

By | February 1, 2014

Until health care becomes truly personalized, race and ethnicity will continue to be important clues guiding medical treatments.

2 Comments

image: Elder Pharmacology

Elder Pharmacology

By | January 1, 2014

Studying and treating the chronic diseases associated with aging needs serious revamping.

5 Comments

image: Three-Way Parenthood

Three-Way Parenthood

By , and | October 1, 2013

Avoiding the transmission of mitochondrial disease takes a trio, but raises a host of logistical issues.

2 Comments

image: Defending Against Plagiarism

Defending Against Plagiarism

By | June 1, 2013

Publishers need to be proactive about detecting and deterring copied text.

5 Comments

image: Misconduct Around the Globe

Misconduct Around the Globe

By | June 1, 2013

Research misconduct is not limited to the developed world, but few countries anywhere are responding adequately.

3 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Genomics-Informed Pathology

Genomics-Informed Pathology

By | January 1, 2013

Twenty-first century lab reports will include test results read by a new breed of pathologist.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech